𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Potent Dendritic Cell Vaccine Loaded with Latent Membrane Protein 2A (LMP2A)

✍ Scribed by Chen, Yun; Yao, Kun; Wang, Bing; Qing, Jian; Liu, Genyan


Book ID
109846430
Publisher
Nature Publishing Group
Year
2008
Tongue
English
Weight
393 KB
Volume
5
Category
Article
ISSN
1672-7681

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The signaling pathways of Epstein-Barr v
✍ Mei-Fong Pang; Kah-Wai Lin; Suat-Cheng Peh πŸ“‚ Article πŸ“… 2009 πŸ› SP Versita 🌐 English βš– 565 KB

## Abstract Epstein-Barr virus (EBV) is a ubiquitous virus with infections commonly resulting in a latency carrier state. Although the exact role of EBV in cancer pathogenesis remains not entirely clear, it is highly probable that it causes several lymphoid and epithelial malignancies, such as Hodg

Epstein-Barr virus latent membrane 2A (L
✍ Fu Chen; Cheng Liu; Charlotta Lindvall; Dawei Xu; Ingemar Ernberg πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 213 KB

## Abstract The latent membrane protein (LMP) 2A, one of the membrane‐spanning polypeptides encoded by the Epstein‐Barr virus (EBV), has been implicated in the maintenance of viral latency and appears to function in part by inhibiting B‐cell receptor (BCR) signaling through its ITAM motifs. It has

Sequence polymorphisms between latent me
✍ Christoph Berger; Sylvia Rothenberger; Edith Bachmann; Cathy McQuain; David Nada πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 59 KB

The latent membrane proteins LMP1 and LMP2A are co-expressed in most malignancies associated with Epstein-Barr virus (EBV). In contrast with the transforming LMP1 oncoprotein, LMP2A is expressed in lymphocytes of healthy EBV carriers and considered to maintain viral latency. Critical for these LMP2A